Mar 28, 2023 | Lung Cancer
2) This program, intended for #healthcare providers, includes updates from #ESMO22 @myESMOIt is supported by an independent educational grant from AstraZeneca. Statement of accreditation and faculty disclosures are at https://t.co/8oShcATovC.— @onc_ce (@onc_ce)...
Feb 19, 2023 | Lung Cancer
2) The faculty for this outstanding program were @peters_solange (Chair) 🇨🇭, @HosseinBorghaei 🇺🇸, Natasha Leighl MD 🇨🇦, and @dplanchard 🇫🇷. A truly international roster of experts in #oncology!Don't miss prior accredited courses in this space at...
Feb 14, 2023 | Lung Cancer
2) Our expert author is Thomas LeBlanc, MD @tomleblancMD, patient experience & cancer outcomes researcher @DukeCancer. Thanks for joining! pic.twitter.com/9lga8yCj76— @onc_ce (@onc_ce) February 15, 2023 4) #PRO in #mNSCLC were a hot topic at #ESMO22. In prior...
Jan 19, 2023 | Lung Cancer
1b) Our expert author is Nicolas Girard @nicogirardcurie, #lungcancer & rare #thoracic #tumors specialist from Institut Curie, Paris @institut_curie. 🇫🇷 Follow us on @onc_ce for the latest updates in #oncology and 🆓CE/#CME! Prior programs for credit at...
Jan 16, 2023 | Lung Cancer
1b) Our expert authors are @NarjustFlorezMD, Assoc. Director CCEP & Thoracic Oncology @DanaFarberNews and her mentee @ShrutiPatelMD, #MedOnc fellow @StanfordCancer. Earn 🆓CE/CME credit for following this 🧵! pic.twitter.com/Kvz0rtScuB— @onc_ce (@onc_ce)...
Jan 9, 2023 | Lung Cancer
2) I am Dr. Sandip Patel @PatelOncology, Professor in Medical Oncology from @UCSDCancer. @nicogirardcurie (to follow) and I will be covering Optimal Immuno-Oncologic Management of Extensive-Stage Small Cell Lung Cancer & Strategies to Develop Individualized...